These are our products available in the Republic of Ireland. For the SPC and PIL information, please click on the product name:
- Alprolix® (eftrenonacog alfa)
- Aspaveli®▼(pegcetacoplan)
- Doptelet®(avatrombopag)
- Elocta® (efmoroctocog alfa)
- Kineret® (anakinra)
- Orfadin® (nitisinone)
- Zynlonta®▼ (loncastuximab tesirine)
Distributed Products
▼ This product is subject to additional monitoring.
Patient safety is a priority for Sobi. We are committed to collect, analyse and react upon any new information about the benefits and risks of our products. If you have information about a side effect or adverse reaction associated with any of our products, please let us know via [email protected] or by calling +44 (0)800 111 4754
You can also report side effects directly to Health Products Regulatory Authority (HPRA) via HPRA Pharmacovigilance, website: www.hpra.ie
For Product Complaints, please contact [email protected]
For Medical Information enquiries, please contact +44 (0)800 111 4754 or email [email protected]
Feb, 2024